Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
21 hedge funds and large institutions have $722K invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 19 → 21 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
76% less capital invested
Capital invested by funds: $3M → $722K (-$2.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$144K |
| 2 |
Walleye Capital
New York
|
+$31.2K |
| 3 |
D.E. Shaw & Co
New York
|
+$21.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.2K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$378 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$52.1K |
| 2 |
CAC
Cowen and Company
New York
|
-$45.2K |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$26.3K |
| 4 |
RA
Royce & Associates
New York
|
-$10.5K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$6.93K |
CANO.WS Hedge Fund Activity: Q3 2023 in Review
21 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q3 2023, worth a combined $722K — down 76% from $3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CANO.WS positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Barclays, adding an estimated $144K. The largest seller was Ionic Capital Management, cutting an estimated $52.1K.
- 21 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q3 2023, up from 19 in Q2 2023.
- Funds reported $722K of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q3 2023, down 76% quarter-over-quarter.
- 5 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q3 2023 and 3 closed out, a net change of +2 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q3 2023 was Barclays, an estimated $144K added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q3 2023 was Ionic Capital Management, an estimated $52.1K sold.
Based on aggregated 13F filings for Q3 2023.